Poland· PL-100139841

Xorimax 500

A cefuroxime product containing cefuroximum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC J01DC02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cefuroximumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefuroxime is registered in 15 of 19 countries.

Countries holding a registration under ATC J01DC02 (cefuroxime), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search cefuroxime products by name

Cefuroxime · ATC J01DC02

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefuroxime costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.0038 in Finland to $4.41 in Switzerland — a ×1160 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefuroxime · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

CH Switzerland$4.41
IT Italy$1.06
FI Finland$0.0038

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Cefuroximum
Manufacturer: Sandoz GmbH
Country: Poland (PL)
ATC code: J01DC02
ATC class: Cefuroxime
Defined daily dose: 0.5 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 5

2 priced

gtin
05907626701760
14 szt.
PLN 49.46
gtin
05909990224456
10 szt.
PLN 38.7
gtin
05909990224463
gtin
05909990763191
gtin
05909990763207

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

210 interactions on record for cefuroxime.

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefuroxime against other medicines How interaction checks work

Cefuroxime · interactions on record

210 records

46 moderate
164 info

Most severe, free to view

Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate
Magnesium hydroxideA02AA04moderate
Kombinationen von AluminiumsalzenA02AB10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefuroxime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefuroxime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Aprokam, Cefuroxim Aptapharma
Belgium · Aprokam, Cefuroxim Fresenius Kabi
Bulgaria · Аксетин, Аксеф
Cyprus · Axetine, Cefurax
Czechia · Aprokam, Axetine
Germany · Aprokam, Cefurax
Denmark · Aprokam, Cefuroxim B. Braun
Estonia · Axetine, Cefuroxime Mip
Spain · Cefuroxima Alter, Cefuroxima Cinfa
Finland · Aprokam, Cefirion
France · Aprokam, Cefuroxime Arrow
United Kingdom (Northern Ireland) · Aprokam, Cefuroxime
Greece · Anaptivan, Cefur
Croatia · Axetine, Beloxim
Hungary · Cefuroxim Kabi, Cefuroxime Aptapharma
Ireland · Aprok, Ceftal
Iceland · Aprokam, Cefuroxim Fresenius Kabi
Italy · Aprokam, Cefuroxima K24 Pharmaceuticals
Lithuania · Axetine, Cefuroxime Mip
Luxembourg · Aprokam, Cefuroxim Fresenius
Latvia · Axetine, Cefuroxime Bcpp
Malta · Axetine, Cefuroxime Axetil Ccav
Netherlands · Aprokam, Cefuroxim Fresenius Kabi
Norway · Aprokam, Cefuroxim B. Braun
Portugal · Antibioxime, Aprokam
Romania · Aprokam, Axetine
Sweden · Aprokam, Cefuroxim Mip
Slovenia · Aprokam, Cefuroksim Aptapharma
Slovakia · Aprokam, Axetine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a90e1bb8-6154-49ec-b983-4fb8349a292c
GET /v1/drugs/a90e1bb8-6154-49ec-b983-4fb8349a292c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909990224456 ¦ Rp ¦ 27649\n10 tabl.\n05909990224463 ¦ Rp ¦ Skasowane ¦ 27650\n10 tabl. w op. foliowym\n05909990763191 ¦ Rp ¦ 27676\n16 tabl.\n05909990763207 ¦ Rp ¦ Skasowane ¦ 42971\n16 tabl. w op. foliowym\n05907626701760 ¦ Rp ¦ 84473\n14 tabl.\nRp ¦ Skasowane ¦ 84474\n14 tabl. w op. foliowym",
  "substance": "Cefuroximum 500 mg",
  "common_name": "Cefuroximum",
  "pl_product_id": "100139841",
  "pozwolenie_nr": "11700",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about cefuroxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console